Encision (OTCMKTS:ECIA – Get Free Report) issued its quarterly earnings results on Wednesday. The medical device company reported ($0.03) EPS for the quarter, Zacks reports. Encision had a negative net margin of 6.05% and a negative return on equity of 22.33%.
Encision Stock Performance
Shares of ECIA stock traded down $0.01 during trading on Friday, reaching $0.14. 12,200 shares of the company’s stock traded hands, compared to its average volume of 4,343. The firm’s 50-day moving average is $0.17 and its 200 day moving average is $0.25. The company has a market capitalization of $2.36 million, a P/E ratio of -4.67 and a beta of 0.87. Encision has a 1 year low of $0.10 and a 1 year high of $0.49. The company has a current ratio of 2.28, a quick ratio of 0.91 and a debt-to-equity ratio of 0.09.
About Encision
Encision, Inc is a U.S.-based medical device company specializing in the development and commercialization of safety solutions for electrosurgery. Founded in the early 1990s, the company’s core mission is to reduce the risk of unintended thermal injuries during surgical procedures by controlling stray electrical current. Encision’s operations focus on research, design, and manufacturing of proprietary instruments and monitoring systems that integrate seamlessly with existing surgical equipment.
At the heart of Encision’s product offering is its Active Electrode Monitoring (AEM) platform.
Read More
- Five stocks we like better than Encision
- Trade this between 9:30 and 10:45 am EST
- New gold price target
- When to buy gold (mathematically)
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Wall Street’s New Sports Prediction Trade
Receive News & Ratings for Encision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encision and related companies with MarketBeat.com's FREE daily email newsletter.
